Atherosclerosis and lymph // risk factors
Article Sidebar
Main Article Content
Downloads
Article Details
Copyright (c) 2020 Kocmur B.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
VanderLaan PA, Reardon CA, Getz GS (2004) Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Atheroscler Tromb Vasc Biol 24: 12-22. Link: https://bit.ly/33XdjZd
Borén J, Chapman JM, Krauss RM, Packard CJ, Bentzon JF, et al. (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal 41: 2313-2330. Link: https://bit.ly/330mQPD
Kocmur B (2017) The Mechanism of the Emergence of Atherosclerosis. New Perspectives SM Atherosclerosis J 1: 1004.
Kocmur B (2020) Atherosclerosis. Yet chylomicrons, large. GlobeEdit may, 2020.
Cardiovascular Diseases (CVDs) (2019). Link: https://bit.ly/364pZ2T
De Ruyter JC, Olthof MR, Seidell JC, Katan MB (2012) A trial of sugar-free or sugar-sweetened beverages and body weight in children. N Engl J Med 367: 1397-1406. Link: https://bit.ly/367VGZs
Milasan A, Smaani A, Martel C (2019) Early rescue of lymphatic function limits atherosclerosis progression in Ldlr−/− mice. Atherosclerosis 283: 106-119. Link: https://bit.ly/2FPEJIt
Raghu P. Kataru, Ju Park H, Baik JE, Claire Li, et al. (2020) Regulation of Lymphatic Function in Obesity. Front Physiol 11: 459. Link: https://bit.ly/3j5FZW7
Lopez-Miranda J, Williams C, Lairon D (2007) Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 98: 458-473. Link: https://bit.ly/364ZV7Z
Hayashi H, Fujimoto K, Cardelli JA, Nutting DF, Bergstedt S, et al. (2020) Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am J Physiol 259. Link: https://bit.ly/2RU071A
Phillips ML, Pullinger C, Kroes I, Kroes J, Hardman DA, et al. (1997) A single copy of apolipoprotein B-48 is present on the human chylomicron remnant. J Lipid Res 38: 1170-1177. Link: https://bit.ly/306FYd4
Thanassoulis G, Afshar M (2019) Atherosclerosis. The Merck Manual of Diagnosis and Therapy for Physicians, Merck & co. Last full review/revision Jul 2019| Content last modified. Link: https://msdmnls.co/3cvA4qR
Nanjee MN, Cooke CJ, Wong JS, Hamilton RL, Olszewski WL, et al. (2001) Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids.J Lipid Res 42: 639-648. Link: https://bit.ly/3iXhGJX
Hansen KC, D’alessandro A, Clement CC, Santambrogio L (2015) Lymph formation, composition and circulation: a proteomics perspective. Int Immunol 27: 219–227. Link: https://bit.ly/3j8tCsA
Miller NE, Olszewski WL, Hattori H, Miller IP, Kujiraoka T, et al. (2013) Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluid. Am J Physiol Endocrinol Metab 304: E321–E328. Link: https://bit.ly/3j4gNPF
Saint-Maurice PF, Troiano RP, Bassett DR, Graubard BI, Carlson SA, et al. (2020) AssociationofDailyStepCountandStepIntensityWithMortalityAmongUSAdults. JAMA 323: 1151-1160. Link: https://bit.ly/340rI6D
A Walter, S Walter (1982) Mast cell density in isolated monkey lungs on exposure to cigarette smoke. Thorax 37: 699–702. Link: https://bit.ly/2G9LX9K
Ereni U, Kum S, Sandikc M, Kara E (2006) Effects of long-term passive smoking on the mast cells in rat lungs. Revue Méd Vét 157: 319-322. Link: https://bit.ly/2RYwo7y
Dallinga-Thie GM, Franssen R, Mooij HL, Visser ME, Hassing HC, et al. (2010) The metabolism of triglyceride-rich lipoproteins revisited; New players, new insight. Atherosclerosis 211: 1-8. Link: https://bit.ly/3cvuDIs
Shi GP, Bot L, Kovanen PT (2015) Mast cells in human and experimental cardiometabolic diseases. Nature Reviews Cardiology 12: 643–658. Link: https://go.nature.com/3cuNseL
Koren E, Kocmur B, Milković S (1976) The role of lungs in the catabolism of chylomicrons in the rat. Period Biol 78: 111-121.
Liu C, Zhang J, Shi GP (2016) Interaction between allergic asthma and atherosclerosis. Transl Res 174: 5–22. Link: https://bit.ly/2RWZ0hB
Noga O, Brunnée T, Schäper C, Kunkel G (1999) Heparin, derived from the mast cells of human lungs is responsible for the generation of kinins in allergic reactions due to the activation of the contact system. Int Arch Allergy Immunol 120: 310-316. Link: https://bit.ly/2RTRBj8